$119 Million is the total value of Opus Point Partners Management, LLC's 65 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 49.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCPT | Buy | RECEPTOS, INC. CMN | $4,234,000 | +50.5% | 25,679 | +11.8% | 3.55% | +27.5% |
| CLVS | Buy | CLOVIS ONCOLOGY INC CMN | $4,156,000 | +174.9% | 55,988 | +107.4% | 3.48% | +132.8% |
| SLXP | Buy | SALIX PHARMACEUTICALS, LTD. CMN | $4,147,000 | +98.4% | 24,000 | +32.0% | 3.48% | +68.1% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC CMN | $4,056,000 | +2.6% | 32,545 | -25.6% | 3.40% | -13.1% |
| INCY | Sell | INCYTE CORPORATION CMN | $4,004,000 | -10.0% | 43,682 | -28.2% | 3.36% | -23.8% |
| MDVN | Sell | MEDIVATION INC. CMN | $3,969,000 | +27.0% | 30,747 | -2.0% | 3.33% | +7.6% |
| REGN | Buy | REGENERON PHARMACEUTICAL INC CMN | $3,950,000 | +11.3% | 8,750 | +1.2% | 3.31% | -5.7% |
| BIIB | Sell | BIOGEN INC. CMN | $3,940,000 | +22.3% | 9,331 | -1.6% | 3.30% | +3.6% |
| SGEN | Buy | SEATTLE GENETICS, INC. CMN | $3,926,000 | +48.6% | 111,050 | +35.0% | 3.29% | +25.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS, INC. CMN | $3,904,000 | +125.1% | 37,388 | +109.2% | 3.27% | +90.7% |
| ISIS | Buy | ISIS PHARMACEUTICALS INC CMN | $3,878,000 | +38.3% | 60,912 | +34.1% | 3.25% | +17.2% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC CMN | $3,870,000 | +11.9% | 32,805 | +12.7% | 3.24% | -5.2% |
| CELG | Buy | CELGENE CORPORATION CMN | $3,838,000 | +3.8% | 33,289 | +0.8% | 3.22% | -12.0% |
| ILMN | Buy | ILLUMINA, INC. CMN | $3,826,000 | +12.7% | 20,609 | +12.0% | 3.21% | -4.5% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC CMN | $3,818,000 | +12.6% | 22,031 | +20.2% | 3.20% | -4.6% |
| ALKS | Buy | ALKERMES PLC CMN | $3,813,000 | +231.6% | 62,546 | +218.6% | 3.20% | +180.8% |
| NKTR | Buy | NEKTAR THERAPEUTICS CMN | $3,692,000 | +0.4% | 335,650 | +41.6% | 3.09% | -14.9% |
| PCYC | Sell | PHARMACYCLICS INC CMN | $3,481,000 | +10.7% | 13,600 | -47.1% | 2.92% | -6.2% |
| CPHD | Sell | CEPHEID INC CMN | $3,112,000 | -4.8% | 54,693 | -9.4% | 2.61% | -19.4% |
| PCRX | New | PACIRA PHARMACEUTICALS, INC. CMN | $3,105,000 | – | 34,949 | +100.0% | 2.60% | – |
| MTD | Sell | METTLER-TOLEDO INTL CMN | $3,101,000 | +2.5% | 9,436 | -5.6% | 2.60% | -13.2% |
| TECH | Buy | BIO TECHNE CORP CMN | $3,101,000 | +20.3% | 30,917 | +10.8% | 2.60% | +1.9% |
| QGEN | Buy | QIAGEN N.V. COMMON SHARES | $3,093,000 | +15.7% | 122,724 | +7.7% | 2.59% | -2.0% |
| BIB | Sell | PROSHARES ULTRA NASDAQ BIOTECHNOLOGY ETFetf | $2,817,000 | -41.2% | 17,784 | -53.4% | 2.36% | -50.2% |
| GEVA | Sell | SYNAGEVA BIOPHARMA CORP CMN | $1,726,000 | -7.0% | 17,700 | -11.5% | 1.45% | -21.2% |
| HOLX | Sell | HOLOGIC INCORPORATED CMN | $1,651,000 | +16.5% | 50,000 | -5.7% | 1.38% | -1.3% |
| ARRY | ARRAY BIOPHARMA INC CMN | $1,474,000 | +55.8% | 200,000 | 0.0% | 1.24% | +31.9% | |
| ESPR | New | ESPERION THERAPEUTICS INC CMN | $1,389,000 | – | 15,000 | +100.0% | 1.16% | – |
| VCEL | Buy | VERICEL CORP CMN | $1,340,000 | +55.6% | 362,157 | +27.8% | 1.12% | +31.8% |
| TSRO | New | TESARO INC CMN | $1,148,000 | – | 20,000 | +100.0% | 0.96% | – |
| STML | Buy | STEMLINE THERAPEUTICS INC CMN | $1,085,000 | -9.7% | 75,000 | +6.5% | 0.91% | -23.5% |
| XNPT | Sell | XENOPORT INC CMN | $926,000 | -30.5% | 130,000 | -14.5% | 0.78% | -41.2% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS, INC. CMN | $912,000 | +8.2% | 60,000 | -14.3% | 0.76% | -8.4% |
| EPZM | Buy | EPIZYME INC CMN | $908,000 | +69.7% | 48,339 | +70.6% | 0.76% | +43.9% |
| UTHR | Sell | UNITED THERAPEUTICS CORP CMN | $899,000 | -63.6% | 5,213 | -72.6% | 0.75% | -69.2% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC CMN | $861,000 | – | 65,000 | +100.0% | 0.72% | – |
| OCRX | Buy | OCERA THERAPEUTICS INC CMN CLASS | $860,000 | +10.1% | 182,673 | +48.9% | 0.72% | -6.7% |
| MACK | MERRIMACK PHARMACEUTICALS INC CMN | $855,000 | +5.0% | 72,009 | 0.0% | 0.72% | -10.9% | |
| TENX | Buy | TENAX THERAPEUTICS INC CMN | $812,000 | -15.1% | 249,004 | +0.1% | 0.68% | -28.0% |
| CLDN | CELLADON CORPORATION CMN | $803,000 | -3.0% | 42,414 | 0.0% | 0.67% | -17.8% | |
| AMGN | Sell | AMGEN INC. CMN | $789,000 | -70.9% | 4,938 | -71.0% | 0.66% | -75.4% |
| FLML | FLAMEL TECHNOLOGIES SPON ADR SPONSORED ADR CMN | $751,000 | +4.9% | 41,788 | 0.0% | 0.63% | -11.2% | |
| RARE | New | ULTRAGENYX PHARMACEUTICAL INC. CMN | $745,000 | – | 12,000 | +100.0% | 0.62% | – |
| MRTX | New | MIRATI THERAPEUTICS INC CMN | $733,000 | – | 25,000 | +100.0% | 0.61% | – |
| BLUE | New | BLUEBIRD BIO INC CMN | $725,000 | – | 6,000 | +100.0% | 0.61% | – |
| CMRX | CHIMERIX, INC. CMN | $722,000 | -6.4% | 19,152 | 0.0% | 0.60% | -20.7% | |
| XNCR | XENCOR, INC. CMN | $685,000 | -4.5% | 44,698 | 0.0% | 0.57% | -19.0% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS INC CMN | $658,000 | +7.3% | 66,704 | +33.4% | 0.55% | -9.2% |
| RLYP | New | RELYPSA, INC. CMN | $649,000 | – | 18,000 | +100.0% | 0.54% | – |
| AERI | New | AERIE PHARMACEUTICALS, INC. CMN | $627,000 | – | 20,000 | +100.0% | 0.53% | – |
| RPRXZ | Buy | WTS/REPROS THERAPEUTICS INC. SERIES B 2.4500 EXP02/07/2016call | $597,000 | +69.1% | 98,000 | +42.9% | 0.50% | +43.3% |
| ARWR | ARROWHEAD RESEARCH CORP CMN | $556,000 | -8.3% | 82,133 | 0.0% | 0.47% | -22.3% | |
| AGIO | Buy | AGIOS PHARMACEUTICALS, INC. CMN | $472,000 | -4.6% | 5,000 | +13.2% | 0.40% | -19.2% |
| MGNX | New | MACROGENICS, INC. CMN | $471,000 | – | 15,000 | +100.0% | 0.40% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC CMN | $459,000 | – | 15,000 | +100.0% | 0.38% | – |
| OMER | New | OMEROS CORPORATION CMN | $441,000 | – | 20,000 | +100.0% | 0.37% | – |
| OTIC | New | OTONOMY INC CMN | $424,000 | – | 12,000 | +100.0% | 0.36% | – |
| ZGNX | New | ZOGENIX, INC. CMN | $411,000 | – | 300,000 | +100.0% | 0.34% | – |
| AAVL | New | AVALANCHE BIOTECHNOLOGIES INC CMN | $405,000 | – | 10,000 | +100.0% | 0.34% | – |
| ACRX | ACELRX PHARMACEUTICALS, INC. CMN | $386,000 | -42.6% | 99,959 | 0.0% | 0.32% | -51.4% | |
| KBIO | Buy | KALOBIOS PHARMACEUTICALS INC CMN | $366,000 | -61.3% | 746,467 | +36.6% | 0.31% | -67.2% |
| GILD | Sell | GILEAD SCIENCES CMN | $358,000 | -12.3% | 3,651 | -15.6% | 0.30% | -25.7% |
| NHLD | New | NATIONAL HOLDINGS CORP CMN | $349,000 | – | 89,530 | +100.0% | 0.29% | – |
| MEIP | New | MEI PHARMA INC CMN | $54,000 | – | 30,000 | +100.0% | 0.04% | – |
| NEPT | New | NEPTUNE TECH & BIORES INC. CMN | $1,000 | – | 36 | +100.0% | 0.00% | – |
| EXAS | Exit | PUT/EXAS @ 21 EXP 04/17/2015put | $0 | – | -50 | -100.0% | -0.01% | – |
| Exit | CALL/PCYC @ 130 EXP 01/17/2015call | $0 | – | -150 | -100.0% | -0.04% | – | |
| Exit | CALL/BIIB @ 355 EXP 01/17/2015call | $0 | – | -120 | -100.0% | -0.27% | – | |
| XOMA | Exit | XOMA CORP DEL CMN | $0 | – | -80,000 | -100.0% | -0.28% | – |
| Exit | CALL/ALXN @ 150 EXP 01/17/2015call | $0 | – | -100 | -100.0% | -0.35% | – | |
| Exit | CALL/INCY @ 70 EXP 01/17/2015call | $0 | – | -886 | -100.0% | -0.48% | – | |
| Exit | CALL/ILMN @ 180 EXP 01/17/2015call | $0 | – | -250 | -100.0% | -0.54% | – | |
| P103PS | Exit | NPS PHARMACEUTICALS INC CMN | $0 | – | -15,471 | -100.0% | -0.55% | – |
| CBST | Exit | CUBIST PHARMACEUTICALS, INC. CMN | $0 | – | -6,502 | -100.0% | -0.65% | – |
| XBI | Exit | SPDR S&P BIOTECH ETF ETFs&p biotech | $0 | – | -20,800 | -100.0% | -3.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-18
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.